Investors

2025 First quarter results announcement

We announced our first quarter 2025 results on April 30.

Quarterly results

Close Video

Every five minutes, someone's life changes with a gynecological cancer diagnosis.

Myelofibrosis is a rare blood cancer affecting 25,000 in the U.S., causing bone marrow scarring.

Ben Schwartz, VP of Oncology, shares his 20-year GSK journey, from drug discovery to leading research.

Our COiMMUNITY Initiative fosters a systematic, collaborative, and approach to boost vaccinations.

As a kid I always enjoyed the simple logic of science and that I could use it to explain the world around me.

Growing up, I loved science and all the prospects that it offered.

We announced our quarter 1 2024 results on Wednesday, May 1st.

Visit our Global site for additional features